Postbiotic

Postbiotics - also known as metabiotics, biogenics, or simply metabolites - are soluble factors (metabolic products or byproducts), secreted by live bacteria, or released after bacterial lysis providing physiological benefits to the host.

However, this term is sometimes also used with regards to paraprobiotics - immobilised probiotics, which when ingested, may have the ability to exert positive biological responses and restore intestinal homeostasis in a similar manner to probiotics. Paraprobiotics are currently being referred to as modified, inactivated, non-viable, para- or ghost probiotics. Probiotics are widely used and accepted in many countries in clinical practice. Paraprobiotics, the immobilised version of probiotics are gaining traction in recent years due to the concerns about the possibility of low tolerance of probiotics, especially in paediatric populations and in severely ill or immunocompromised patients. Paraprobiotics seem to have similar beneficial properties as live probiotics with fewer of the constraints associated with unstable, diminishing bacteria.

Paraprobiotics types
Paraprobiotics could be generated using different methods:
 * Heat-inactivation (also includes tyndallisation)
 * Ultraviolet-inactivated
 * Chemical treatment (e.g. formalin)
 * Gamma-irradiation
 * Sonication

In most cases heat treatment is considered the method of choice for deactivating probiotic strains. The effect that different types of inactivation have on bacterial structure and components as well as the maintenance of probiotic properties requires further research.

Mechanism of action
The mechanisms of action for paraprobiotics is less understood, though the possible mechanisms include immune system regulation and interference with pathogen attachment to host cells. Limited research hypothesises that immobilised paraprobiotics release key bacterial components, such as lipoteichoic acids, peptidoglycans, or exopolysaccharides which exhibit key immunomodulating effects and antagonising properties against pathogens.

General paraprobiotics applications
As paraprobiotics are newly emerging, so is the evidence to support the use of paraprobiotics. Emerging clinical and pre-clinical studies have demonstrated that paraprobiotics play a role in general health and well-being and for improving host immune function like that of probiotics. It is postulated that paraprobiotics induce changes in the gut microbiome and the altered gut microbial composition which are associated with increased levels of innate and acquired immunity biomarkers. Paraprobiotics also seem to exhibit antioxidant effects highlighting their potential applications in food and pharmaceutical industries.

Paraprobiotics applications in biotherapy
Paraprobiotics (mostly heat-killed) have been evaluated in small study sizes and seem to be beneficial for the following clinical applications:


 * Gastrointestinal diseases (bloating, paediatric disorders, infantile colic, diarrhea, extra-intestinal diseases)
 * Upper respiratory tract infections
 * Ocular disorders including eye fatigue
 * There is a growing body of pre-clinical evidence supporting the use of paraprobiotics for the following applications:
 * Asthma
 * Inflammatory bowel diseases (ulcerative colitis)
 * Colitis-associated colorectal cancer
 * Type 2 Diabetes (improved glycemic parameters)
 * Liver injury
 * Atopic dermatitis
 * Influenza viruses
 * Cardiac injury

Species used as paraprobiotics
Many species of bacteria have been identified to have benefits as paraprobiotic strains:


 * Bifidobacterium breve
 * Bifidobacterium infantis
 * Bifidobacterium longum
 * Enterococcus faecalis
 * Lactobacillus acidophilus
 * Lactobacillus brevis
 * Lactobacillus bulgaricus
 * Lactobacillus casei
 * Lactobacillus delbrueckii subsp. Bulgaricus
 * Lactobacillus fermentum
 * Lactobacillus johnsonii
 * Lactobacillus paracasei
 * Lactobacillus plantarum
 * Lactobacillus reuteri
 * Lactobacillus salivarius
 * Lactococcus lactis
 * Streptococcus salivarius subsp. thermophilus